ID   CP1A1_HUMAN             Reviewed;         512 AA.
AC   P04798; A4F3V9; A4F3W0; Q53G18;
DT   13-AUG-1987, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1988, sequence version 1.
DT   10-MAY-2017, entry version 196.
DE   RecName: Full=Cytochrome P450 1A1;
DE            EC=1.14.14.1;
DE   AltName: Full=CYPIA1;
DE   AltName: Full=Cytochrome P450 form 6;
DE   AltName: Full=Cytochrome P450-C;
DE   AltName: Full=Cytochrome P450-P1;
GN   Name=CYP1A1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2989797; DOI=10.1093/nar/13.12.4503;
RA   Jaiswal A.K., Gonzales F.J., Nebert D.W.;
RT   "Human P1-450 gene sequence and correlation of mRNA with genetic
RT   differences in benzo[a]pyrene metabolism.";
RL   Nucleic Acids Res. 13:4503-4520(1985).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=3838385; DOI=10.1126/science.3838385;
RA   Jaiswal A.K., Gonzalez F.J., Nebert D.W.;
RT   "Human dioxin-inducible cytochrome P1-450: complementary DNA and amino
RT   acid sequence.";
RL   Science 228:80-83(1985).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Placenta;
RX   PubMed=3019683; DOI=10.1111/j.1432-1033.1986.tb09857.x;
RA   Kawajiri K., Watanabe J., Gotoh O., Tagashira Y., Sogawa K.,
RA   Fujii-Kuriyama Y.;
RT   "Structure and drug inducibility of the human cytochrome P-450c
RT   gene.";
RL   Eur. J. Biochem. 159:219-225(1986).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=11207026; DOI=10.1097/00008571-200102000-00001;
RA   Corchero J., Pimprale S., Kimura S., Gonzalez F.J.;
RT   "Organization of the CYP1A cluster on human chromosome 15:
RT   implications for gene regulation.";
RL   Pharmacogenetics 11:1-6(2001).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2 AND 3).
RC   TISSUE=Blood;
RA   Graebsch C., Bauer M.;
RT   "Cloning and sequencing of new alternative splicing variants of human
RT   CYP1A1 gene.";
RL   Submitted (FEB-2006) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   ASP-45.
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R.,
RA   Fahey J., Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G.,
RA   Johnson E., Jones C., Kamat A., Kaur A., Locke D.P., Madan A.,
RA   Munson G., Jaffe D.B., Lui A., Macdonald P., Mauceli E., Naylor J.W.,
RA   Nesbitt R., Nicol R., O'Leary S.B., Ratcliffe A., Rounsley S., She X.,
RA   Sneddon K.M.B., Stewart S., Sougnez C., Stone S.M., Topham K.,
RA   Vincent D., Wang S., Zimmer A.R., Birren B.W., Hood L., Lander E.S.,
RA   Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human
RT   chromosome 15.";
RL   Nature 440:671-675(2006).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Cervix;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 282-425 (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=9500998; DOI=10.1006/bbrc.1998.8171;
RA   Yun C.H., Park H.J., Kim S.J., Kim H.K.;
RT   "Identification of cytochrome P450 1A1 in human brain.";
RL   Biochem. Biophys. Res. Commun. 243:808-810(1998).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 295-484 (ISOFORM 1).
RX   PubMed=3000715; DOI=10.1089/dna.1985.4.395;
RA   Quattrochi L.C., Okino S.T., Pendurthi U.R., Tukey R.H.;
RT   "Cloning and isolation of human cytochrome P-450 cDNAs homologous to
RT   dioxin-inducible rabbit mRNAs encoding P-450 4 and P-450 6.";
RL   DNA 4:395-400(1985).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 35-512 IN COMPLEX WITH HEME
RP   AND INHIBITOR ALPHA-NAPHTOFLAVONE, AND COFACTOR.
RX   PubMed=23508959; DOI=10.1074/jbc.M113.452953;
RA   Walsh A.A., Szklarz G.D., Scott E.E.;
RT   "Human cytochrome P450 1A1 structure and utility in understanding drug
RT   and xenobiotic metabolism.";
RL   J. Biol. Chem. 288:12932-12943(2013).
RN   [13]
RP   VARIANT VAL-462.
RX   PubMed=1722803; DOI=10.1093/oxfordjournals.jbchem.a123594;
RA   Hayashi S., Watanabe J., Nakachi K., Kawajiri K.;
RT   "Genetic linkage of lung cancer-associated MspI polymorphisms with
RT   amino acid replacement in the heme binding region of the human
RT   cytochrome P450IA1 gene.";
RL   J. Biochem. 110:407-411(1991).
RN   [14]
RP   VARIANT ASN-461.
RX   PubMed=8895751;
RA   Cascorbi I., Brockmoller J., Roots I.;
RT   "A C4887A polymorphism in exon 7 of human CYP1A1: population
RT   frequency, mutation linkages, and impact on lung cancer
RT   susceptibility.";
RL   Cancer Res. 56:4965-4969(1996).
RN   [15]
RP   VARIANT TRP-279.
RX   PubMed=10739168; DOI=10.1097/00008571-200002000-00003;
RA   Smart J., Daly A.K.;
RT   "Variation in induced CYP1A1 levels: relationship to CYP1A1, Ah
RT   receptor and GSTM1 polymorphisms.";
RL   Pharmacogenetics 10:11-24(2000).
RN   [16]
RP   VARIANTS ILE-331 AND SER-464.
RX   PubMed=11295847; DOI=10.1002/humu.48;
RA   Chevalier D., Allorge D., Lo-Guidice J.-M., Cauffiez C., Lhermitte M.,
RA   Lafitte J.-J., Broly F.;
RT   "Detection of known and two novel (M331I and R464S) missense mutations
RT   in the human CYP1A1 gene in a French Caucasian population.";
RL   Hum. Mutat. 17:355-355(2001).
RN   [17]
RP   VARIANTS ASN-448; CYS-464; TRP-477 AND ARG-492.
RX   PubMed=15618738; DOI=10.2133/dmpk.18.218;
RA   Saito M., Egashira M., Kiyotani K., Fujieda M., Yamazaki H.,
RA   Kiyohara C., Kunitoh H., Kamataki T.;
RT   "Novel nonsynonymous polymorphisms of the CYP1A1 Gene in Japanese.";
RL   Drug Metab. Pharmacokinet. 18:218-222(2003).
RN   [18]
RP   VARIANTS ASP-45; THR-78; TRP-93; ARG-173; ASN-461; MET-482 AND
RP   ARG-492.
RX   PubMed=15469410; DOI=10.1517/14622416.5.7.895;
RA   Solus J.F., Arietta B.J., Harris J.R., Sexton D.P., Steward J.Q.,
RA   McMunn C., Ihrie P., Mehall J.M., Edwards T.L., Dawson E.P.;
RT   "Genetic variation in eleven phase I drug metabolism genes in an
RT   ethnically diverse population.";
RL   Pharmacogenomics 5:895-931(2004).
RN   [19]
RP   VARIANTS ASP-45; THR-78; ASN-461 AND VAL-462.
RX   PubMed=15643613; DOI=10.1002/humu.20134;
RA   Jiang Z., Dalton T.P., Jin L., Wang B., Tsuneoka Y., Shertzer H.G.,
RA   Deka R., Nebert D.W.;
RT   "Toward the evaluation of function in genetic variability:
RT   characterizing human SNP frequencies and establishing BAC-transgenic
RT   mice carrying the human CYP1A1_CYP1A2 locus.";
RL   Hum. Mutat. 25:196-206(2005).
RN   [20]
RP   VARIANT [LARGE SCALE ANALYSIS] TRP-477.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Cytochromes P450 are a group of heme-thiolate
CC       monooxygenases. In liver microsomes, this enzyme is involved in an
CC       NADPH-dependent electron transport pathway. It oxidizes a variety
CC       of structurally unrelated compounds, including steroids, fatty
CC       acids, and xenobiotics.
CC   -!- CATALYTIC ACTIVITY: RH + [reduced NADPH--hemoprotein reductase] +
CC       O(2) = ROH + [oxidized NADPH--hemoprotein reductase] + H(2)O.
CC   -!- COFACTOR:
CC       Name=heme; Xref=ChEBI:CHEBI:30413;
CC         Evidence={ECO:0000269|PubMed:23508959};
CC   -!- INTERACTION:
CC       Q96DZ9:CMTM5; NbExp=3; IntAct=EBI-10194262, EBI-2548702;
CC       Q96DZ9-2:CMTM5; NbExp=3; IntAct=EBI-10194262, EBI-11522780;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Peripheral
CC       membrane protein. Microsome membrane; Peripheral membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P04798-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P04798-2; Sequence=VSP_053364, VSP_053365;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=P04798-3; Sequence=VSP_053363, VSP_053366;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Lung, lymphocytes and placenta.
CC   -!- INDUCTION: By 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).
CC   -!- SIMILARITY: Belongs to the cytochrome P450 family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Cytochrome P450 Allele Nomenclature Committee;
CC       Note=CYP1A1 alleles;
CC       URL="http://www.cypalleles.ki.se/cyp1a1.htm";
CC   -!- WEB RESOURCE: Name=SHMPD; Note=The Singapore human mutation and
CC       polymorphism database;
CC       URL="http://shmpd.bii.a-star.edu.sg/gene.php?genestart=A&genename=CYP1A1";
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=CYP1A1 entry;
CC       URL="https://en.wikipedia.org/wiki/CYP1A1";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X02612; CAA26458.1; -; Genomic_DNA.
DR   EMBL; K03191; AAA52139.1; -; mRNA.
DR   EMBL; X04300; CAA27843.1; -; Genomic_DNA.
DR   EMBL; AF253322; AAK25727.1; -; Genomic_DNA.
DR   EMBL; AM233518; CAJ80721.1; -; mRNA.
DR   EMBL; AM233519; CAJ80722.1; -; mRNA.
DR   EMBL; AM233520; CAJ80723.1; -; mRNA.
DR   EMBL; AK223113; BAD96833.1; -; mRNA.
DR   EMBL; AC091230; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC023019; AAH23019.1; -; mRNA.
DR   EMBL; M12079; AAA52152.1; -; mRNA.
DR   EMBL; AF040259; AAD10199.1; -; mRNA.
DR   CCDS; CCDS10268.1; -. [P04798-1]
DR   PIR; A24797; O4HU6.
DR   RefSeq; NP_000490.1; NM_000499.4. [P04798-1]
DR   RefSeq; NP_001306145.1; NM_001319216.1.
DR   RefSeq; NP_001306146.1; NM_001319217.1. [P04798-1]
DR   UniGene; Hs.72912; -.
DR   PDB; 4I8V; X-ray; 2.60 A; A/B/C/D=35-512.
DR   PDBsum; 4I8V; -.
DR   ProteinModelPortal; P04798; -.
DR   SMR; P04798; -.
DR   BioGrid; 107923; 70.
DR   IntAct; P04798; 1.
DR   STRING; 9606.ENSP00000369050; -.
DR   BindingDB; P04798; -.
DR   ChEMBL; CHEMBL2231; -.
DR   DrugBank; DB02342; 2-Methoxyestradiol.
DR   DrugBank; DB00316; Acetaminophen.
DR   DrugBank; DB00518; Albendazole.
DR   DrugBank; DB01118; Amiodarone.
DR   DrugBank; DB00381; Amlodipine.
DR   DrugBank; DB00613; Amodiaquine.
DR   DrugBank; DB01169; Arsenic trioxide.
DR   DrugBank; DB00972; Azelastine.
DR   DrugBank; DB04957; Azimilide.
DR   DrugBank; DB04975; Banoxantrone.
DR   DrugBank; DB06770; Benzyl alcohol.
DR   DrugBank; DB01393; Bezafibrate.
DR   DrugBank; DB00201; Caffeine.
DR   DrugBank; DB01136; Carvedilol.
DR   DrugBank; DB00608; Chloroquine.
DR   DrugBank; DB00356; Chlorzoxazone.
DR   DrugBank; DB00169; Cholecalciferol.
DR   DrugBank; DB00568; Cinnarizine.
DR   DrugBank; DB01407; Clenbuterol.
DR   DrugBank; DB01013; Clobetasol propionate.
DR   DrugBank; DB00636; Clofibrate.
DR   DrugBank; DB00882; Clomifene.
DR   DrugBank; DB00575; Clonidine.
DR   DrugBank; DB00363; Clozapine.
DR   DrugBank; DB00851; Dacarbazine.
DR   DrugBank; DB06292; Dapagliflozin.
DR   DrugBank; DB01254; Dasatinib.
DR   DrugBank; DB00694; Daunorubicin.
DR   DrugBank; DB04840; Debrisoquin.
DR   DrugBank; DB01234; Dexamethasone.
DR   DrugBank; DB00633; Dexmedetomidine.
DR   DrugBank; DB00586; Diclofenac.
DR   DrugBank; DB00804; Dicyclomine.
DR   DrugBank; DB00470; Dronabinol.
DR   DrugBank; DB08846; Ellagic Acid.
DR   DrugBank; DB00530; Erlotinib.
DR   DrugBank; DB00783; Estradiol.
DR   DrugBank; DB00655; Estrone.
DR   DrugBank; DB00898; Ethanol.
DR   DrugBank; DB04841; Flunarizine.
DR   DrugBank; DB00693; Fluorescein.
DR   DrugBank; DB00499; Flutamide.
DR   DrugBank; DB01095; Fluvastatin.
DR   DrugBank; DB00176; Fluvoxamine.
DR   DrugBank; DB00317; Gefitinib.
DR   DrugBank; DB00889; Granisetron.
DR   DrugBank; DB00502; Haloperidol.
DR   DrugBank; DB01064; Isoprenaline.
DR   DrugBank; DB01167; Itraconazole.
DR   DrugBank; DB01026; Ketoconazole.
DR   DrugBank; DB00448; Lansoprazole.
DR   DrugBank; DB04871; Lorcaserin.
DR   DrugBank; DB00643; Mebendazole.
DR   DrugBank; DB01065; Melatonin.
DR   DrugBank; DB00170; Menadione.
DR   DrugBank; DB00553; Methoxsalen.
DR   DrugBank; DB01388; Mibefradil.
DR   DrugBank; DB00184; Nicotine.
DR   DrugBank; DB01115; Nifedipine.
DR   DrugBank; DB00325; Nitroprusside.
DR   DrugBank; DB01059; Norfloxacin.
DR   DrugBank; DB00338; Omeprazole.
DR   DrugBank; DB01092; Ouabain.
DR   DrugBank; DB00526; Oxaliplatin.
DR   DrugBank; DB00738; Pentamidine.
DR   DrugBank; DB03783; Phenacetin.
DR   DrugBank; DB01174; Phenobarbital.
DR   DrugBank; DB00466; Picrotoxin.
DR   DrugBank; DB00457; Prazosin.
DR   DrugBank; DB01087; Primaquine.
DR   DrugBank; DB00396; Progesterone.
DR   DrugBank; DB00818; Propofol.
DR   DrugBank; DB00571; Propranolol.
DR   DrugBank; DB00165; Pyridoxine.
DR   DrugBank; DB00908; Quinidine.
DR   DrugBank; DB00468; Quinine.
DR   DrugBank; DB01129; Rabeprazole.
DR   DrugBank; DB02709; Resveratrol.
DR   DrugBank; DB00740; Riluzole.
DR   DrugBank; DB08931; Riociguat.
DR   DrugBank; DB06176; Romidepsin.
DR   DrugBank; DB00203; Sildenafil.
DR   DrugBank; DB00428; Streptozocin.
DR   DrugBank; DB00605; Sulindac.
DR   DrugBank; DB00675; Tamoxifen.
DR   DrugBank; DB04905; Tesmilifene.
DR   DrugBank; DB00624; Testosterone.
DR   DrugBank; DB01041; Thalidomide.
DR   DrugBank; DB00277; Theophylline.
DR   DrugBank; DB00730; Thiabendazole.
DR   DrugBank; DB00208; Ticlopidine.
DR   DrugBank; DB00539; Toremifene.
DR   DrugBank; DB00755; Tretinoin.
DR   DrugBank; DB00197; Troglitazone.
DR   DrugBank; DB00162; Vitamin A.
DR   DrugBank; DB00682; Warfarin.
DR   GuidetoPHARMACOLOGY; 1318; -.
DR   SwissLipids; SLP:000001329; -.
DR   iPTMnet; P04798; -.
DR   PhosphoSitePlus; P04798; -.
DR   BioMuta; CYP1A1; -.
DR   DMDM; 117139; -.
DR   MaxQB; P04798; -.
DR   PaxDb; P04798; -.
DR   PeptideAtlas; P04798; -.
DR   PRIDE; P04798; -.
DR   DNASU; 1543; -.
DR   Ensembl; ENST00000379727; ENSP00000369050; ENSG00000140465. [P04798-1]
DR   Ensembl; ENST00000395048; ENSP00000378488; ENSG00000140465. [P04798-1]
DR   Ensembl; ENST00000562201; ENSP00000455340; ENSG00000140465. [P04798-2]
DR   Ensembl; ENST00000564596; ENSP00000457668; ENSG00000140465. [P04798-3]
DR   Ensembl; ENST00000567032; ENSP00000456585; ENSG00000140465. [P04798-1]
DR   Ensembl; ENST00000569630; ENSP00000455051; ENSG00000140465. [P04798-2]
DR   GeneID; 1543; -.
DR   KEGG; hsa:1543; -.
DR   UCSC; uc002ayp.4; human. [P04798-1]
DR   CTD; 1543; -.
DR   DisGeNET; 1543; -.
DR   GeneCards; CYP1A1; -.
DR   HGNC; HGNC:2595; CYP1A1.
DR   HPA; CAB018654; -.
DR   MIM; 108330; gene.
DR   neXtProt; NX_P04798; -.
DR   OpenTargets; ENSG00000140465; -.
DR   PharmGKB; PA27092; -.
DR   eggNOG; KOG0156; Eukaryota.
DR   eggNOG; COG2124; LUCA.
DR   GeneTree; ENSGT00760000118992; -.
DR   HOGENOM; HOG000036991; -.
DR   HOVERGEN; HBG106944; -.
DR   InParanoid; P04798; -.
DR   KO; K07408; -.
DR   OMA; RYDHNHQ; -.
DR   OrthoDB; EOG091G0BT8; -.
DR   PhylomeDB; P04798; -.
DR   TreeFam; TF105095; -.
DR   Reactome; R-HSA-1989781; PPARA activates gene expression.
DR   Reactome; R-HSA-211981; Xenobiotics.
DR   Reactome; R-HSA-2142670; Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET).
DR   Reactome; R-HSA-2142816; Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE).
DR   SABIO-RK; P04798; -.
DR   ChiTaRS; CYP1A1; human.
DR   GeneWiki; Cytochrome_P450,_family_1,_member_A1; -.
DR   GenomeRNAi; 1543; -.
DR   PRO; PR:P04798; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; ENSG00000140465; -.
DR   CleanEx; HS_CYP1A1; -.
DR   ExpressionAtlas; P04798; baseline and differential.
DR   Genevisible; P04798; HS.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IBA:GO_Central.
DR   GO; GO:0005739; C:mitochondrion; IEA:Ensembl.
DR   GO; GO:0031090; C:organelle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0070330; F:aromatase activity; IEA:UniProtKB-EC.
DR   GO; GO:0032451; F:demethylase activity; IEA:Ensembl.
DR   GO; GO:0019899; F:enzyme binding; IEA:Ensembl.
DR   GO; GO:0101020; F:estrogen 16-alpha-hydroxylase activity; IDA:BHF-UCL.
DR   GO; GO:0016711; F:flavonoid 3'-monooxygenase activity; IEA:Ensembl.
DR   GO; GO:0020037; F:heme binding; IEA:InterPro.
DR   GO; GO:0005506; F:iron ion binding; IEA:InterPro.
DR   GO; GO:0004497; F:monooxygenase activity; TAS:Reactome.
DR   GO; GO:0016491; F:oxidoreductase activity; IDA:BHF-UCL.
DR   GO; GO:0016679; F:oxidoreductase activity, acting on diphenols and related substances as donors; IEA:Ensembl.
DR   GO; GO:0019825; F:oxygen binding; TAS:Reactome.
DR   GO; GO:0070576; F:vitamin D 24-hydroxylase activity; IDA:BHF-UCL.
DR   GO; GO:0042904; P:9-cis-retinoic acid biosynthetic process; IEA:Ensembl.
DR   GO; GO:0007568; P:aging; IEA:Ensembl.
DR   GO; GO:0043010; P:camera-type eye development; IEA:Ensembl.
DR   GO; GO:0008283; P:cell proliferation; IEA:Ensembl.
DR   GO; GO:0071280; P:cellular response to copper ion; IEA:Ensembl.
DR   GO; GO:0071407; P:cellular response to organic cyclic compound; IDA:MGI.
DR   GO; GO:0009804; P:coumarin metabolic process; IEA:Ensembl.
DR   GO; GO:0019341; P:dibenzo-p-dioxin catabolic process; IEA:Ensembl.
DR   GO; GO:0048565; P:digestive tract development; IEA:Ensembl.
DR   GO; GO:0017144; P:drug metabolic process; IDA:BHF-UCL.
DR   GO; GO:0019373; P:epoxygenase P450 pathway; TAS:Reactome.
DR   GO; GO:0009692; P:ethylene metabolic process; TAS:Reactome.
DR   GO; GO:0009812; P:flavonoid metabolic process; IEA:Ensembl.
DR   GO; GO:0070365; P:hepatocyte differentiation; IEA:Ensembl.
DR   GO; GO:0017143; P:insecticide metabolic process; IEA:Ensembl.
DR   GO; GO:0002933; P:lipid hydroxylation; IDA:BHF-UCL.
DR   GO; GO:0060137; P:maternal process involved in parturition; IEA:Ensembl.
DR   GO; GO:0097267; P:omega-hydroxylase P450 pathway; TAS:Reactome.
DR   GO; GO:0055114; P:oxidation-reduction process; IDA:BHF-UCL.
DR   GO; GO:0006778; P:porphyrin-containing compound metabolic process; IEA:Ensembl.
DR   GO; GO:1900087; P:positive regulation of G1/S transition of mitotic cell cycle; IEA:Ensembl.
DR   GO; GO:0046677; P:response to antibiotic; IEA:Ensembl.
DR   GO; GO:0046685; P:response to arsenic-containing substance; IEA:Ensembl.
DR   GO; GO:0042493; P:response to drug; IEA:Ensembl.
DR   GO; GO:0032094; P:response to food; IEA:Ensembl.
DR   GO; GO:0009635; P:response to herbicide; IEA:Ensembl.
DR   GO; GO:0055093; P:response to hyperoxia; IEA:Ensembl.
DR   GO; GO:0001666; P:response to hypoxia; IEA:Ensembl.
DR   GO; GO:0035902; P:response to immobilization stress; IEA:Ensembl.
DR   GO; GO:0010041; P:response to iron(III) ion; IEA:Ensembl.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl.
DR   GO; GO:0009624; P:response to nematode; IEA:Ensembl.
DR   GO; GO:0009615; P:response to virus; IEA:Ensembl.
DR   GO; GO:0033189; P:response to vitamin A; IEA:Ensembl.
DR   GO; GO:0009611; P:response to wounding; IEA:Ensembl.
DR   GO; GO:0008202; P:steroid metabolic process; IDA:BHF-UCL.
DR   GO; GO:0042359; P:vitamin D metabolic process; IC:BHF-UCL.
DR   InterPro; IPR001128; Cyt_P450.
DR   InterPro; IPR017972; Cyt_P450_CS.
DR   InterPro; IPR002401; Cyt_P450_E_grp-I.
DR   InterPro; IPR008066; Cyt_P450_E_grp-I_CYP1.
DR   Pfam; PF00067; p450; 1.
DR   PRINTS; PR00463; EP450I.
DR   PRINTS; PR01683; EP450ICYP1A.
DR   PRINTS; PR00385; P450.
DR   SUPFAM; SSF48264; SSF48264; 1.
DR   PROSITE; PS00086; CYTOCHROME_P450; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome;
KW   Endoplasmic reticulum; Glycoprotein; Heme; Iron; Membrane;
KW   Metal-binding; Microsome; Monooxygenase; Oxidoreductase; Polymorphism;
KW   Reference proteome.
FT   CHAIN         1    512       Cytochrome P450 1A1.
FT                                /FTId=PRO_0000051627.
FT   METAL       457    457       Iron (heme axial ligand).
FT                                {ECO:0000269|PubMed:23508959}.
FT   BINDING     224    224       Substrate. {ECO:0000269|PubMed:23508959}.
FT   CARBOHYD     67     67       O-linked (GlcNAc) serine. {ECO:0000250}.
FT   VAR_SEQ       1    261       Missing (in isoform 3).
FT                                {ECO:0000303|Ref.5}.
FT                                /FTId=VSP_053363.
FT   VAR_SEQ     189    189       Y -> T (in isoform 2).
FT                                {ECO:0000303|Ref.5}.
FT                                /FTId=VSP_053364.
FT   VAR_SEQ     190    512       Missing (in isoform 2).
FT                                {ECO:0000303|Ref.5}.
FT                                /FTId=VSP_053365.
FT   VAR_SEQ     419    512       Missing (in isoform 3).
FT                                {ECO:0000303|Ref.5}.
FT                                /FTId=VSP_053366.
FT   VARIANT      45     45       G -> D (in dbSNP:rs4646422).
FT                                {ECO:0000269|PubMed:15469410,
FT                                ECO:0000269|PubMed:15643613,
FT                                ECO:0000269|Ref.6}.
FT                                /FTId=VAR_023194.
FT   VARIANT      66     66       M -> V (in dbSNP:rs35035798).
FT                                /FTId=VAR_033817.
FT   VARIANT      78     78       I -> T (in dbSNP:rs17861094).
FT                                {ECO:0000269|PubMed:15469410,
FT                                ECO:0000269|PubMed:15643613}.
FT                                /FTId=VAR_023195.
FT   VARIANT      93     93       R -> W (in dbSNP:rs2229150).
FT                                {ECO:0000269|PubMed:15469410}.
FT                                /FTId=VAR_024706.
FT   VARIANT     173    173       T -> R (in dbSNP:rs28399427).
FT                                {ECO:0000269|PubMed:15469410}.
FT                                /FTId=VAR_024707.
FT   VARIANT     279    279       R -> W (in dbSNP:rs34260157).
FT                                {ECO:0000269|PubMed:10739168}.
FT                                /FTId=VAR_009280.
FT   VARIANT     286    286       I -> T (in dbSNP:rs4987133).
FT                                /FTId=VAR_020122.
FT   VARIANT     331    331       M -> I (in allele CYP1A1*6;
FT                                dbSNP:rs56313657).
FT                                {ECO:0000269|PubMed:11295847}.
FT                                /FTId=VAR_016937.
FT   VARIANT     448    448       I -> N (in allele CYP1A1*8;
FT                                dbSNP:rs72547509).
FT                                {ECO:0000269|PubMed:15618738}.
FT                                /FTId=VAR_016938.
FT   VARIANT     461    461       T -> N (in allele CYP1A1*4;
FT                                dbSNP:rs1799814).
FT                                {ECO:0000269|PubMed:15469410,
FT                                ECO:0000269|PubMed:15643613,
FT                                ECO:0000269|PubMed:8895751}.
FT                                /FTId=VAR_008342.
FT   VARIANT     462    462       I -> V (in allele CYP1A1*2B and allele
FT                                CYP1A1*2C; dbSNP:rs1048943).
FT                                {ECO:0000269|PubMed:15643613,
FT                                ECO:0000269|PubMed:1722803}.
FT                                /FTId=VAR_001243.
FT   VARIANT     464    464       R -> C (in allele CYP1A1*9;
FT                                dbSNP:rs41279188).
FT                                {ECO:0000269|PubMed:15618738}.
FT                                /FTId=VAR_016939.
FT   VARIANT     464    464       R -> S (in allele CYP1A1*5;
FT                                dbSNP:rs41279188).
FT                                {ECO:0000269|PubMed:11295847}.
FT                                /FTId=VAR_016940.
FT   VARIANT     470    470       F -> V (in dbSNP:rs36121583).
FT                                /FTId=VAR_033818.
FT   VARIANT     477    477       R -> W (in allele CYP1A1*10;
FT                                dbSNP:rs56240201).
FT                                {ECO:0000269|PubMed:15618738,
FT                                ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_016941.
FT   VARIANT     482    482       V -> M (in dbSNP:rs28399429).
FT                                {ECO:0000269|PubMed:15469410}.
FT                                /FTId=VAR_024708.
FT   VARIANT     492    492       P -> R (in allele CYP1A1*11;
FT                                dbSNP:rs28399430).
FT                                {ECO:0000269|PubMed:15469410,
FT                                ECO:0000269|PubMed:15618738}.
FT                                /FTId=VAR_016942.
FT   CONFLICT     26     26       I -> M (in Ref. 2; AAA52139).
FT                                {ECO:0000305}.
FT   CONFLICT    235    235       D -> E (in Ref. 2; AAA52139).
FT                                {ECO:0000305}.
FT   CONFLICT    381    381       F -> L (in Ref. 1; CAA26458).
FT                                {ECO:0000305}.
FT   TURN         47     49       {ECO:0000244|PDB:4I8V}.
FT   HELIX        52     55       {ECO:0000244|PDB:4I8V}.
FT   HELIX        59     70       {ECO:0000244|PDB:4I8V}.
FT   STRAND       72     78       {ECO:0000244|PDB:4I8V}.
FT   STRAND       81     86       {ECO:0000244|PDB:4I8V}.
FT   HELIX        89     96       {ECO:0000244|PDB:4I8V}.
FT   TURN         97     99       {ECO:0000244|PDB:4I8V}.
FT   HELIX       100    103       {ECO:0000244|PDB:4I8V}.
FT   HELIX       110    114       {ECO:0000244|PDB:4I8V}.
FT   HELIX       116    118       {ECO:0000244|PDB:4I8V}.
FT   TURN        121    123       {ECO:0000244|PDB:4I8V}.
FT   HELIX       129    145       {ECO:0000244|PDB:4I8V}.
FT   HELIX       158    179       {ECO:0000244|PDB:4I8V}.
FT   HELIX       186    203       {ECO:0000244|PDB:4I8V}.
FT   HELIX       212    218       {ECO:0000244|PDB:4I8V}.
FT   STRAND      219    221       {ECO:0000244|PDB:4I8V}.
FT   HELIX       224    228       {ECO:0000244|PDB:4I8V}.
FT   HELIX       233    235       {ECO:0000244|PDB:4I8V}.
FT   HELIX       238    242       {ECO:0000244|PDB:4I8V}.
FT   HELIX       246    271       {ECO:0000244|PDB:4I8V}.
FT   HELIX       281    292       {ECO:0000244|PDB:4I8V}.
FT   STRAND      296    298       {ECO:0000244|PDB:4I8V}.
FT   STRAND      300    302       {ECO:0000244|PDB:4I8V}.
FT   HELIX       304    308       {ECO:0000244|PDB:4I8V}.
FT   HELIX       310    334       {ECO:0000244|PDB:4I8V}.
FT   HELIX       337    350       {ECO:0000244|PDB:4I8V}.
FT   HELIX       359    364       {ECO:0000244|PDB:4I8V}.
FT   HELIX       366    379       {ECO:0000244|PDB:4I8V}.
FT   STRAND      394    396       {ECO:0000244|PDB:4I8V}.
FT   STRAND      399    401       {ECO:0000244|PDB:4I8V}.
FT   STRAND      406    410       {ECO:0000244|PDB:4I8V}.
FT   HELIX       411    415       {ECO:0000244|PDB:4I8V}.
FT   TURN        418    420       {ECO:0000244|PDB:4I8V}.
FT   HELIX       429    432       {ECO:0000244|PDB:4I8V}.
FT   STRAND      435    437       {ECO:0000244|PDB:4I8V}.
FT   HELIX       441    444       {ECO:0000244|PDB:4I8V}.
FT   HELIX       453    455       {ECO:0000244|PDB:4I8V}.
FT   HELIX       460    477       {ECO:0000244|PDB:4I8V}.
FT   STRAND      478    481       {ECO:0000244|PDB:4I8V}.
FT   STRAND      495    497       {ECO:0000244|PDB:4I8V}.
FT   STRAND      506    510       {ECO:0000244|PDB:4I8V}.
SQ   SEQUENCE   512 AA;  58165 MW;  3C62366044148EFD CRC64;
     MLFPISMSAT EFLLASVIFC LVFWVIRASR PQVPKGLKNP PGPWGWPLIG HMLTLGKNPH
     LALSRMSQQY GDVLQIRIGS TPVVVLSGLD TIRQALVRQG DDFKGRPDLY TFTLISNGQS
     MSFSPDSGPV WAARRRLAQN GLKSFSIASD PASSTSCYLE EHVSKEAEVL ISTLQELMAG
     PGHFNPYRYV VVSVTNVICA ICFGRRYDHN HQELLSLVNL NNNFGEVVGS GNPADFIPIL
     RYLPNPSLNA FKDLNEKFYS FMQKMVKEHY KTFEKGHIRD ITDSLIEHCQ EKQLDENANV
     QLSDEKIINI VLDLFGAGFD TVTTAISWSL MYLVMNPRVQ RKIQEELDTV IGRSRRPRLS
     DRSHLPYMEA FILETFRHSS FVPFTIPHST TRDTSLKGFY IPKGRCVFVN QWQINHDQKL
     WVNPSEFLPE RFLTPDGAID KVLSEKVIIF GMGKRKCIGE TIARWEVFLF LAILLQRVEF
     SVPLGVKVDM TPIYGLTMKH ACCEHFQMQL RS
//
